vs
FEDERAL AGRICULTURAL MORTGAGE CORP（AGM）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是FEDERAL AGRICULTURAL MORTGAGE CORP的1.9倍（$207.3M vs $107.5M），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 6.1%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 7.1%）
联邦农业抵押贷款公司（又称Farmer Mac）是由美国国会1988年依据《1987年农业信贷法案》设立、由股东持股的联邦特许企业，核心业务是搭建农业不动产及住房抵押贷款的二级市场，提升农业领域的信贷流动性，为农户、牧场主及乡村社区提供长期稳定的信贷支持。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
AGM vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $107.5M | $207.3M |
| 净利润 | — | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 56.3% | -54.7% |
| 净利率 | — | -62.0% |
| 营收同比 | 6.1% | 25.9% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $3.69 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $107.5M | $207.3M | ||
| Q3 25 | $104.0M | $159.9M | ||
| Q2 25 | $102.6M | $166.5M | ||
| Q1 25 | $94.3M | $139.3M | ||
| Q4 24 | $101.3M | $164.6M | ||
| Q3 24 | $90.3M | $139.5M | ||
| Q2 24 | $89.9M | $147.0M | ||
| Q1 24 | $93.7M | $108.8M |
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $55.0M | $-180.4M | ||
| Q2 25 | $54.8M | $-115.0M | ||
| Q1 25 | $49.7M | $-151.1M | ||
| Q4 24 | $56.5M | $-133.2M | ||
| Q3 24 | $49.8M | $-133.5M | ||
| Q2 24 | $47.1M | $-131.6M | ||
| Q1 24 | $53.7M | $-170.7M |
| Q4 25 | 56.3% | -54.7% | ||
| Q3 25 | 64.1% | -106.9% | ||
| Q2 25 | 63.8% | -64.8% | ||
| Q1 25 | 66.9% | -102.6% | ||
| Q4 24 | 67.5% | -74.3% | ||
| Q3 24 | 69.0% | -94.6% | ||
| Q2 24 | 65.9% | -79.1% | ||
| Q1 24 | 72.8% | -151.9% |
| Q4 25 | — | -62.0% | ||
| Q3 25 | 52.9% | -112.8% | ||
| Q2 25 | 53.4% | -69.0% | ||
| Q1 25 | 52.6% | -108.5% | ||
| Q4 24 | 55.8% | -80.9% | ||
| Q3 24 | 55.2% | -95.7% | ||
| Q2 24 | 52.4% | -89.5% | ||
| Q1 24 | 57.4% | -156.8% |
| Q4 25 | $3.69 | $-1.28 | ||
| Q3 25 | $4.44 | $-1.81 | ||
| Q2 25 | $4.48 | $-1.17 | ||
| Q1 25 | $4.01 | $-1.57 | ||
| Q4 24 | $4.62 | $-1.34 | ||
| Q3 24 | $3.86 | $-1.40 | ||
| Q2 24 | $3.68 | $-1.52 | ||
| Q1 24 | $4.28 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $421.0M |
| 总债务越低越好 | $30.8B | — |
| 股东权益账面价值 | $1.7B | $-80.0M |
| 总资产 | $35.4B | $1.5B |
| 负债/权益比越低杠杆越低 | 17.93× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $421.0M | ||
| Q3 25 | — | $202.5M | ||
| Q2 25 | — | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $174.0M | ||
| Q3 24 | $842.1M | $150.6M | ||
| Q2 24 | $923.0M | $480.7M | ||
| Q1 24 | $745.1M | $112.3M |
| Q4 25 | $30.8B | — | ||
| Q3 25 | $29.2B | — | ||
| Q2 25 | $28.9B | — | ||
| Q1 25 | $28.0B | — | ||
| Q4 24 | $27.5B | — | ||
| Q3 24 | $27.2B | — | ||
| Q2 24 | $26.8B | — | ||
| Q1 24 | $26.8B | — |
| Q4 25 | $1.7B | $-80.0M | ||
| Q3 25 | $1.7B | $9.2M | ||
| Q2 25 | $1.5B | $151.3M | ||
| Q1 25 | $1.5B | $144.2M | ||
| Q4 24 | $1.5B | $255.0M | ||
| Q3 24 | $1.5B | $346.8M | ||
| Q2 24 | $1.5B | $432.4M | ||
| Q1 24 | $1.5B | $140.3M |
| Q4 25 | $35.4B | $1.5B | ||
| Q3 25 | $33.4B | $1.2B | ||
| Q2 25 | $33.0B | $1.3B | ||
| Q1 25 | $31.8B | $1.3B | ||
| Q4 24 | $31.3B | $1.5B | ||
| Q3 24 | $30.6B | $1.5B | ||
| Q2 24 | $30.2B | $1.6B | ||
| Q1 24 | $29.8B | $1.3B |
| Q4 25 | 17.93× | — | ||
| Q3 25 | 17.31× | — | ||
| Q2 25 | 18.70× | — | ||
| Q1 25 | 18.39× | — | ||
| Q4 24 | 18.48× | — | ||
| Q3 24 | 18.60× | — | ||
| Q2 24 | 17.87× | — | ||
| Q1 24 | 18.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | 0.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $80.1M | $-99.8M | ||
| Q3 25 | $74.2M | $-91.4M | ||
| Q2 25 | $-47.7M | $-108.3M | ||
| Q1 25 | $-49.8M | $-166.5M | ||
| Q4 24 | $612.6M | $-79.3M | ||
| Q3 24 | $-44.4M | $-67.0M | ||
| Q2 24 | $56.1M | $-77.0M | ||
| Q1 24 | $233.3M | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | $607.4M | $-79.5M | ||
| Q3 24 | $-44.4M | $-68.6M | ||
| Q2 24 | $52.6M | $-79.0M | ||
| Q1 24 | $231.7M | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | 599.8% | -48.3% | ||
| Q3 24 | -49.2% | -49.2% | ||
| Q2 24 | 58.5% | -53.7% | ||
| Q1 24 | 247.3% | -178.2% |
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 5.2% | 0.1% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 4.0% | 1.4% | ||
| Q1 24 | 1.7% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | -0.87× | — | ||
| Q1 25 | -1.00× | — | ||
| Q4 24 | 10.84× | — | ||
| Q3 24 | -0.89× | — | ||
| Q2 24 | 1.19× | — | ||
| Q1 24 | 4.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGM
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
